Skip to content
healthcare.dev

Topamax

NDC 50458-641, topiramate, tablet, coated, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-641
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020505
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-641 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE100 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
50458-641-655045806416560 TABLET, COATED in 1 BOTTLE (50458-641-65)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/21628112-0c47-11df-95b3-498d55d89593
  • NADAC price for package 50458064165

    GET /v1/drugs/nadac/50458064165

Use it

Look up 50458-641 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-641 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-641. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.